中西药联用风险因素评估与处方审核、干预的相关分析

Correlation Analysis of Risk Factor Assessment and Prescription Review and Intervention of Chinese and Western Drugs

目的:中西药联用风险因素评估与处方审核、干预的相关分析。方法:统计2014年4月至2018年3月间每年本院中西药联用处方数,于2016年4月起应用中西药联用风险因素识别与评估、处方审核与干预模式,对比分析四年的处方不合格率。结果:进行干预模式前,每年的中西药联用处方不合格率无明显差异,进行干预后每年中西药联用处方不合格率明显下降。结论:引入风险管理药方干预模式可有效的促进医院药房中西药联用的处方审核规范化及标准化,该模式值得进行推广与应用。

Objective:To analyze the risk factors of Chinese and Western medicines combined with prescription audits and interventions.Methods:To count the number of prescriptions for Chinese and Western medicines in the hospital from April 2014 to March 2018,and to apply them from April 2016 onwards.The traditional Chinese medicine and Western medicine were used to identify and evaluate risk factors,prescription examination and intervention models,and compared the four-year prescription failure rate.Result:Before the intervention model,there was no significant difference in the annual failure rate of Chinese and Western drug combination prescriptions.After the intervention,the rate of unqualified prescriptions of Chinese and Western medicines combined each year decreased significantly.Conclusion:The introduction of risk management drug intervention model can effectively promote the standardization and standardization of the prescription review of hospital pharmacy western medicine,which is worthy of promotion and application.